Gene: CHRM3

1131
EGBRS|HM3|PBS
cholinergic receptor muscarinic 3
protein-coding
1q43
Ensembl:ENSG00000133019 MIM:118494 Vega:OTTHUMG00000039649 UniprotKB:P20309
NG_032046.2
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
1.840e-1 (AD)  8.946e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs12080951chr1:239615360 (GRCh38.p7)C>Talcohol dependenceSNV(Single Nucleotide Variation)
rs12135445chr1:239579957 (GRCh38.p7)G>Aalcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
KIAA1549L0.971
KCNJ30.964
DLGAP10.963
AAK10.961
SV2B0.961
PRICKLE10.96
ATRNL10.959
EPHA40.959
OLFM30.958
KCTD160.958

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
HEY2-0.615
RAB13-0.6
ACAP1-0.599
MYL3-0.578
YES1-0.573
SNHG18-0.573
WWTR1-0.572
CMTM3-0.57
CSAG1-0.57
EMP3-0.569

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB00185CevimelineSmall Molecule107233-08-9ApprovedTarget
DB00193TramadolSmall Molecule27203-92-5Approved|InvestigationalTarget
DB00202SuccinylcholineSmall Molecule306-40-1ApprovedTarget
DB00246ZiprasidoneSmall Molecule146939-27-7ApprovedTarget
DB00280DisopyramideSmall Molecule3737-09-5ApprovedTarget
DB00321AmitriptylineSmall Molecule50-48-6ApprovedTarget
DB00332Ipratropium bromideSmall Molecule22254-24-6ApprovedTarget
DB00334OlanzapineSmall Molecule132539-06-1Approved|InvestigationalTarget
DB00340MetixeneSmall Molecule4969-02-2ApprovedTarget
DB00342TerfenadineSmall Molecule50679-08-8Approved|WithdrawnTarget
DB00363ClozapineSmall Molecule5786-21-0ApprovedTarget
DB00376TrihexyphenidylSmall Molecule144-11-6ApprovedTarget
DB00383OxyphencyclimineSmall Molecule125-53-1ApprovedTarget
DB00387ProcyclidineSmall Molecule77-37-2ApprovedTarget
DB00408LoxapineSmall Molecule1977-10-2ApprovedTarget
DB00411CarbacholSmall Molecule51-83-2ApprovedTarget
DB00420PromazineSmall Molecule58-40-2ApprovedTarget
DB00424HyoscyamineSmall Molecule101-31-5ApprovedTarget
DB00434CyproheptadineSmall Molecule129-03-3ApprovedTarget
DB00458ImipramineSmall Molecule50-49-7ApprovedTarget
DB00462Methylscopolamine bromideSmall Molecule155-41-9ApprovedTarget
DB00477ChlorpromazineSmall Molecule50-53-3Approved|InvestigationalTarget
DB00496DarifenacinSmall Molecule133099-04-4Approved|InvestigationalTarget
DB00505TridihexethylSmall Molecule60-49-1WithdrawnTarget
DB00517Anisotropine MethylbromideSmall Molecule80-50-2ApprovedTarget
DB00540NortriptylineSmall Molecule72-69-5ApprovedTarget
DB00572AtropineSmall Molecule51-55-8ApprovedTarget
DB00599ThiopentalSmall Molecule76-75-5ApprovedTarget
DB00622NicardipineSmall Molecule55985-32-5Approved|InvestigationalTarget
DB00715ParoxetineSmall Molecule61869-08-7Approved|InvestigationalTarget
DB00725Homatropine MethylbromideSmall Molecule80-49-9ApprovedTarget
DB00729Diphemanil MethylsulfateSmall Molecule62-97-5Approved|WithdrawnTarget
DB00747ScopolamineSmall Molecule51-34-3Approved|InvestigationalTarget
DB00767BenzquinamideSmall Molecule63-12-7WithdrawnTarget
DB00777PropiomazineSmall Molecule362-29-8ApprovedTarget
DB00785CryptenamineSmall Molecule1356-18-9ApprovedTarget
DB00809TropicamideSmall Molecule1508-75-4Approved|InvestigationalTarget
DB00835BrompheniramineSmall Molecule86-22-6ApprovedTarget
DB00934MaprotilineSmall Molecule10262-69-8Approved|InvestigationalTarget
DB00986GlycopyrroniumSmall Molecule740028-90-4Approved|InvestigationalTarget
DB01019BethanecholSmall Molecule674-38-4ApprovedTarget
DB01036TolterodineSmall Molecule124937-51-5Approved|InvestigationalTarget
DB01062OxybutyninSmall Molecule5633-20-5Approved|InvestigationalTarget
DB01069PromethazineSmall Molecule60-87-7Approved|InvestigationalTarget
DB01085PilocarpineSmall Molecule92-13-7Approved|InvestigationalTarget
DB01142DoxepinSmall Molecule1668-19-5Approved|InvestigationalTarget
DB01151DesipramineSmall Molecule50-47-5Approved|InvestigationalTarget
DB01224QuetiapineSmall Molecule111974-69-7ApprovedTarget
DB01226MivacuriumSmall Molecule133814-19-4ApprovedTarget
DB01231DiphenidolSmall Molecule972-02-1Approved|Investigational|WithdrawnTarget
DB01238AripiprazoleSmall Molecule129722-12-9Approved|InvestigationalTarget
DB01239ChlorprothixeneSmall Molecule113-59-7Approved|Investigational|WithdrawnTarget
DB01337PancuroniumSmall Molecule-ApprovedTarget
DB01338PipecuroniumSmall Molecule68399-58-6ApprovedTarget
DB01403MethotrimeprazineSmall Molecule60-99-1Approved|InvestigationalTarget
DB01409TiotropiumSmall Molecule186691-13-4ApprovedTarget
DB01591SolifenacinSmall Molecule242478-37-1ApprovedTarget
DB01625IsopropamideSmall Molecule7492-32-2ApprovedTarget
DB03128AcetylcholineSmall Molecule51-84-3ApprovedTarget
DB04365ArecolineSmall Molecule63-75-2ExperimentalTarget
DB04843MepenzolateSmall Molecule25990-43-6ApprovedTarget
DB04924ItoprideSmall Molecule122898-67-3InvestigationalTarget
DB05752ALKS 27Small Molecule-InvestigationalTarget
DB06702FesoterodineSmall Molecule286930-02-7ApprovedTarget
DB06709MethacholineSmall Molecule55-92-5Approved|InvestigationalTarget
DB06787HexocycliumSmall Molecule6004-98-4ApprovedTarget
DB08897AclidiniumSmall Molecule727649-81-2ApprovedTarget
DB09076UmeclidiniumSmall Molecule869185-19-3ApprovedTarget
DB09167DosulepinSmall Molecule113-53-1ApprovedTarget
DB09262ImidafenacinSmall Molecule170105-16-5Approved|InvestigationalTarget
DB09300ButylscopolamineSmall Molecule7182-53-8Approved|InvestigationalTarget
DB09357DexpanthenolSmall Molecule81-13-0ApprovedTarget
DB00454PethidineSmall Molecule57-42-1ApprovedTarget
DB00543AmoxapineSmall Molecule14028-44-5ApprovedTarget
DB00555LamotrigineSmall Molecule84057-84-1Approved|InvestigationalTarget
DB00568CinnarizineSmall Molecule298-57-7Approved|InvestigationalTarget
DB00726TrimipramineSmall Molecule739-71-9ApprovedTarget
DB01221KetamineSmall Molecule6740-88-1ApprovedTarget
DB09194EtoperidoneSmall Molecule52942-31-1WithdrawnTarget
ID Drug Name Action PubMed
C425227(1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine"(1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine analog binds to and results in decreased activity of CHRM3 protein"11206470
C425227(1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine"(1-(2,2-diphenyl-(1,3)dioxolan-4-yl)-ethyl)-dimethyl-amine binds to and results in decreased activity of CHRM3 protein"11206470
C0519421-hexacosanol1-hexacosanol inhibits the reaction [Streptozocin affects the expression of CHRM3 mRNA]17989502
C1111182',3,3',4',5-pentachloro-4-hydroxybiphenyl"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CHRM3 mRNA"19114083
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C0423754-diphenylacetoxy-1,1-dimethylpiperidinium"4-diphenylacetoxy-1,1-dimethylpiperidinium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]"9846649
C0423754-diphenylacetoxy-1,1-dimethylpiperidinium"4-diphenylacetoxy-1,1-dimethylpiperidinium inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]"11306684
C0423754-diphenylacetoxy-1,1-dimethylpiperidinium"4-diphenylacetoxy-1,1-dimethylpiperidinium binds to and results in decreased activity of CHRM3 protein"10353596|1168919
C0423754-diphenylacetoxy-1,1-dimethylpiperidinium"4-diphenylacetoxy-1,1-dimethylpiperidinium results in decreased activity of CHRM3 protein"15115163
C5196694-diphenylacetoxy-N-methylpiperidine methobromide4-diphenylacetoxy-N-methylpiperidine methobromide binds to and results in decreased activity of CHRM3 protein15105209
C5196694-diphenylacetoxy-N-methylpiperidine methobromideMetoclopramide inhibits the reaction [4-diphenylacetoxy-N-methylpiperidine methobromide binds to CHRM3 protein]15105209
C0582974-fluorohexahydrosiladifenidol4-fluorohexahydrosiladifenidol binds to and results in decreased activity of CHRM3 protein10353596
C5685165-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide"5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide binds to CHRM3 protein"21870878
C0084465-methylfurtrethoniumbrucine promotes the reaction [5-methylfurtrethonium binds to CHRM3 protein]9224827
C0084465-methylfurtrethoniumCHRM3 protein binds to 5-methylfurtrethonium9224827
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
D000109AcetylcholineAcetylcholine results in increased activity of CHRM3 protein10101037
D000109AcetylcholineN-chloromethylbrucine promotes the reaction [Acetylcholine results in increased activity of CHRM3 protein]10101037
D000109AcetylcholineCHRM3 protein affects the susceptibility to Acetylcholine18367213
D000109AcetylcholineAcetylcholine binds to and results in increased activity of CHRM3 protein10101037
D000109AcetylcholineAcetylcholine binds to CHRM3 protein10069518|9495826
D000109Acetylcholinebrucine analog affects the reaction [Acetylcholine binds to CHRM3 protein]10069518
D000109Acetylcholinebrucine N-oxide promotes the reaction [Acetylcholine binds to CHRM3 protein]9495826
D000109Acetylcholinebrucine promotes the reaction [Acetylcholine binds to CHRM3 protein]9224827
D000109AcetylcholineCHRM3 protein binds to Acetylcholine9224827
D000109AcetylcholineN-chloromethylbrucine promotes the reaction [Acetylcholine binds to CHRM3 protein]9495826
D000109AcetylcholineN-chloromethylbrucine promotes the reaction [Acetylcholine results in increased activity of CHRM3 protein]10101037
D000109AcetylcholineAcetylcholine results in increased activity of CHRM3 protein15964566
D000109AcetylcholineCHRM3 protein results in increased susceptibility to Acetylcholine15964566|1940701
D000109AcetylcholineAcetylcholine binds to CHRM3 protein12435818
D000109AcetylcholineAcetylcholine results in increased activity of CHRM3 protein11755166
D000109AcetylcholinePregnenolone inhibits the reaction [Acetylcholine binds to CHRM3 protein]15900516
D000109AcetylcholineProgesterone inhibits the reaction [Acetylcholine binds to CHRM3 protein]15900516
D000109AcetylcholineWIN 62577 analog inhibits the reaction [Acetylcholine binds to CHRM3 protein]12435818
D000109AcetylcholineWIN 62577 promotes the reaction [Acetylcholine binds to CHRM3 protein]12435818
D000109AcetylcholineAcetylcholine results in increased activity of [CHRM3 protein co-treated with TRPV1 protein]18826653
D000109Acetylcholinecapsazepine inhibits the reaction [Acetylcholine results in increased activity of [CHRM3 protein co-treated with TRPV1 protein]]18826653
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM3 mRNA]29253600
D000143AcidsCHRM3 protein affects the reaction [GAST protein results in increased secretion of Acids]14724830
D000143AcidsCHRM3 protein affects the reaction [Histamine results in increased secretion of Acids]14724830
D000143AcidsCHRM3 protein affects the secretion of Acids14724830
D000171AcroleinAcrolein results in increased expression of CHRM3 protein17941892
D020106AcrylamideAcrylamide affects the expression of CHRM3 mRNA28959563
D016604Aflatoxin B1Aflatoxin B1 affects the expression of CHRM3 protein20106945
D016604Aflatoxin B1Aflatoxin B1 results in increased methylation of CHRM3 gene27153756
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CHRM3 mRNA23630614
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in decreased expression of CHRM3 mRNA28522335
C439263AM 1241AM 1241 binds to CHRM3 protein18931146
D000643Ammonium ChlorideAmmonium Chloride affects the expression of CHRM3 mRNA16483693
D018501Antirheumatic AgentsAntirheumatic Agents results in increased expression of CHRM3 mRNA24449571
D001115Arecolinebrucine promotes the reaction [Arecoline binds to CHRM3 protein]9224827
D001115ArecolineCHRM3 protein binds to Arecoline9224827
D001151ArsenicArsenic affects the methylation of CHRM3 gene25304211
C006632arsenic trioxidearsenic trioxide results in decreased expression of CHRM3 mRNA26705709
D001280AtrazineAtrazine results in decreased expression of CHRM3 mRNA25929836
D001285AtropineAtropine binds to and results in decreased activity of CHRM3 protein15140916
D001285AtropineAtropine inhibits the reaction [Carbachol results in increased activity of CHRM3 protein]20708676
D001285AtropineAtropine binds to and results in decreased activity of CHRM3 protein17613726
C487081belinostatbelinostat results in increased expression of CHRM3 mRNA26272509
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
D004958Estradiol[Estradiol co-treated with Plant Preparations] results in decreased expression of CHRM3 mRNA26945725
D018723Bethanecholbrucine promotes the reaction [Bethanechol binds to CHRM3 protein]9224827
D018723BethanecholCHRM3 protein binds to Bethanechol9224827
C006780bisphenol A[bisphenol A co-treated with Genistein] results in increased methylation of CHRM3 gene28505145
C006780bisphenol Abisphenol A results in decreased expression of CHRM3 mRNA25181051|2710353
C006780bisphenol Abisphenol A results in increased expression of CHRM3 mRNA29097150
C006780bisphenol Abisphenol A results in increased methylation of CHRM3 gene28505145
C083806brucinebrucine analog affects the reaction [Acetylcholine binds to CHRM3 protein]10069518
C083806brucinebrucine analog affects the reaction [N-Methylscopolamine binds to CHRM3 protein]10069518
C083806brucinebrucine binds to and results in increased activity of CHRM3 protein mutant form20466821
C083806brucinebrucine binds to CHRM3 protein15647330
C083806brucinebrucine promotes the reaction [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [5-methylfurtrethonium binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [Acetylcholine binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [Arecoline binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [Bethanechol binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [Carbachol binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [Carbachol results in increased activity of CHRM3 protein mutant form]20466821
C083806brucinebrucine promotes the reaction [furtrethonium binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [oxotremorine M binds to CHRM3 protein]9224827
C083806brucinebrucine promotes the reaction [Pilocarpine binds to CHRM3 protein]9224827
C083067brucine N-oxidebrucine N-oxide promotes the reaction [Acetylcholine binds to CHRM3 protein]9495826
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of CHRM3 mRNA23741332
D019256Cadmium ChlorideAcetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM3 mRNA]29253600
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of CHRM3 mRNA29253600
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of CHRM3 mRNA27389774
D019256Cadmium ChlorideQuercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM3 mRNA]27389774
C071423capsazepinecapsazepine inhibits the reaction [Acetylcholine results in increased activity of [CHRM3 protein co-treated with TRPV1 protein]]18826653
C006890caracurinecaracurine binds to CHRM3 protein15647330
D002217CarbacholAtropine inhibits the reaction [Carbachol results in increased activity of CHRM3 protein]20708676
D002217Carbacholbrucine promotes the reaction [Carbachol binds to CHRM3 protein]9224827
D002217Carbacholbrucine promotes the reaction [Carbachol results in increased activity of CHRM3 protein mutant form]20466821
D002217CarbacholCarbachol binds to and results in increased activity of CHRM3 protein20466821
D002217CarbacholCarbachol binds to and results in increased activity of CHRM3 protein mutant form20466821
D002217CarbacholCarbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]20708676
D002217CarbacholCarbachol results in increased activity of CHRM3 protein20708676
D002217CarbacholCHRM3 protein binds to Carbachol9224827
D002217CarbacholGuanylyl Imidodiphosphate inhibits the reaction [Carbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]]20708676
D002217CarbacholZinc Oxide promotes the reaction [Carbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]]20708676
D002217CarbacholCHRM3 protein affects the susceptibility to Carbachol14724830
D002217CarbacholCHRM3 protein results in increased susceptibility to Carbachol19407017
D002217Carbachol[Metoclopramide binds to and results in decreased activity of CHRM3 protein] which results in decreased susceptibility to Carbachol15105209
D002217CarbacholCarbachol results in increased activity of CHRM3 protein15255942|1595502
D002217CarbacholEthanol inhibits the reaction [Carbachol results in increased activity of CHRM3 protein]15255942
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of CHRM3 mRNA16644059
D008455(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloridebrucine promotes the reaction [(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride binds to CHRM3 protein]9224827
D008455(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium ChlorideCHRM3 protein binds to (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride9224827
D004390ChlorpyrifosChlorpyrifos results in decreased activity of CHRM3 protein17666426
D004390ChlorpyrifosChlorpyrifos results in decreased expression of CHRM3 mRNA18812211
D003300CopperCopper deficiency results in increased expression of CHRM3 mRNA26033743
D003435Crotalid VenomsCrotalid Venoms inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]10845706
D003471CuprizoneCuprizone results in decreased expression of CHRM3 mRNA26577399
C101207darifenacindarifenacin binds to and results in decreased activity of CHRM3 protein15140916
C101207darifenacindarifenacin binds to and results in decreased activity of CHRM3 protein11488427
D003847DeoxyglucoseCHRM3 protein affects the susceptibility to Deoxyglucose14724830
D003976DiazinonDiazinon results in increased expression of CHRM3 mRNA16207942
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of CHRM3 mRNA15620428
D004006DichlorvosDichlorvos results in decreased expression of CHRM3 protein19100812
D004054DiethylstilbestrolDiethylstilbestrol results in decreased expression of CHRM3 mRNA21658437
D002117CalcitriolCalcitriol results in decreased expression of CHRM3 mRNA21592394
D002117Calcitriol[Testosterone co-treated with Calcitriol] results in decreased expression of CHRM3 mRNA21592394
D004117DimethoateDimethoate results in increased expression of CHRM3 mRNA15033005
D004117DimethoateDimethoate results in decreased expression of CHRM3 mRNA15033006
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in decreased expression of CHRM3 mRNA"22485181
D004222DisulfotonDisulfoton results in decreased expression of CHRM3 mRNA8856746
C118739entinostatentinostat results in increased expression of CHRM3 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
D004785Environmental PollutantsEnvironmental Pollutants results in decreased expression of CHRM3 mRNA22872703
D000431EthanolEthanol inhibits the reaction [Carbachol results in increased activity of CHRM3 protein]15255942
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of CHRM3 mRNA29097150
C044894ethylcholine aziridiniumethylcholine aziridinium results in increased expression of CHRM3 mRNA10733153
C044894ethylcholine aziridiniumethylcholine aziridinium results in increased expression of CHRM3 protein10733153
D005459FluoridesFluorides results in decreased expression of CHRM3 mRNA25417050
D005459FluoridesFluorides results in decreased expression of CHRM3 protein25417050
D005632FructoseFructose results in increased expression of CHRM3 mRNA17707055
D005632FructoseFructose results in increased expression of CHRM3 protein17707055
C039281furanfuran results in increased expression of CHRM3 mRNA25539665
C028530furtrethoniumbrucine promotes the reaction [furtrethonium binds to CHRM3 protein]9224827
C028530furtrethoniumCHRM3 protein binds to furtrethonium9224827
D005703Gallamine TriethiodideGallamine Triethiodide inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D005703Gallamine TriethiodideGallamine Triethiodide binds to CHRM3 protein12435818
D019833Genistein[bisphenol A co-treated with Genistein] results in increased methylation of CHRM3 gene28505145
C004312glycidolglycidol results in decreased expression of CHRM3 mRNA24915197
D006165Guanylyl ImidodiphosphateGuanylyl Imidodiphosphate inhibits the reaction [Carbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]]20708676
C046773hexahydrosiladifenidolhexahydrosiladifenidol inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]8744975
C046773hexahydrosiladifenidolhexahydrosiladifenidol binds to and results in decreased activity of CHRM3 protein8028781|8744975|
D006632HistamineCHRM3 protein affects the reaction [Histamine results in increased secretion of Acids]14724830
D006632HistamineCHRM3 protein affects the susceptibility to Histamine14724830
D006843Hydrocarbons, Chlorinated"Hydrocarbons, Chlorinated results in decreased expression of CHRM3 mRNA"22872703
D006851Hydrochloric AcidCHRM3 protein affects the susceptibility to Hydrochloric Acid18367213
D006851Hydrochloric AcidHydrochloric Acid results in decreased expression of CHRM3 protein20719367
D007295Inositol Phosphates[Taurolithocholic Acid binds to and affects the activity of CHRM3 protein] which results in increased abundance of Inositol Phosphates12379313
D007649KetamineKetamine inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]12456425
C057416KT 5720KT 5720 binds to CHRM3 protein12435818
D007854LeadLead results in increased expression of CHRM3 mRNA19921347
C054938methoctraminemethoctramine inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]12507038
D008731MethoxychlorMethoxychlor results in increased expression of CHRM3 mRNA27103539
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of CHRM3 mRNA28001369
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of CHRM3 mRNA"19285098
D008743Methyl ParathionMethyl Parathion results in decreased activity of CHRM3 protein17666426
D019832N-Methylscopolamine"4-diphenylacetoxy-1,1-dimethylpiperidinium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]"9846649
D019832N-Methylscopolaminebrucine analog affects the reaction [N-Methylscopolamine binds to CHRM3 protein]10069518
D019832N-MethylscopolamineCarbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]20708676
D019832N-MethylscopolamineCHRM3 protein binds to N-Methylscopolamine9224827
D019832N-MethylscopolamineGallamine Triethiodide inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D019832N-MethylscopolamineGuanylyl Imidodiphosphate inhibits the reaction [Carbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]]20708676
D019832N-MethylscopolamineN-Methylscopolamine binds to CHRM3 protein10069518|1564733
D019832N-MethylscopolaminePancuronium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D019832N-MethylscopolaminePipecuronium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D019832N-Methylscopolaminerocuronium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D019832N-MethylscopolamineVecuronium Bromide inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D019832N-MethylscopolamineZinc Oxide promotes the reaction [Carbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]]20708676
D019832N-MethylscopolamineN-Methylscopolamine binds to CHRM3 protein12435818
D008787Metoclopramide[Metoclopramide binds to and results in decreased activity of CHRM3 protein] which results in decreased susceptibility to Carbachol15105209
D008787MetoclopramideMetoclopramide binds to CHRM3 protein15105209
D008787MetoclopramideMetoclopramide inhibits the reaction [4-diphenylacetoxy-N-methylpiperidine methobromide binds to CHRM3 protein]15105209
C523799MRK 003CHRM3 results in increased susceptibility to MRK 00319903844
C074183N-(2-chloroethyl)-4-piperidinyl diphenylacetateN-(2-chloroethyl)-4-piperidinyl diphenylacetate binds to and results in decreased activity of CHRM3 protein10353596
D009255NafenopinNafenopin results in increased expression of CHRM3 protein10903494
C118330N-chloromethylbrucineN-chloromethylbrucine promotes the reaction [Acetylcholine results in increased activity of CHRM3 protein]10101037
C118330N-chloromethylbrucineN-chloromethylbrucine promotes the reaction [Acetylcholine binds to CHRM3 protein]9495826
C118330N-chloromethylbrucineN-chloromethylbrucine promotes the reaction [Acetylcholine results in increased activity of CHRM3 protein]10101037
D009532NickelNickel results in decreased expression of CHRM3 mRNA24768652|2558310
C042743oxotremorine Mbrucine promotes the reaction [oxotremorine M binds to CHRM3 protein]9224827
C042743oxotremorine MCHRM3 protein binds to oxotremorine M9224827
C005419oxybutyninoxybutynin binds to and results in decreased activity of CHRM3 protein15140916
D010197PancuroniumPancuronium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of CHRM3 mRNA26272509
D010261ParaoxonParaoxon results in decreased expression of CHRM3 mRNA21787676
D052638Particulate MatterParticulate Matter results in increased expression of CHRM3 mRNA26916448
D052638Particulate MatterParticulate Matter results in increased expression of CHRM3 protein26916448
D052638Particulate MatterSB 203580 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 mRNA]26916448
D052638Particulate MatterSB 203580 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 protein]26916448
D052638Particulate MatterU 0126 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 mRNA]26916448
D052638Particulate MatterU 0126 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 protein]26916448
C086401pentabromodiphenyl etherpentabromodiphenyl ether affects the expression of CHRM3 mRNA27294297
C000593032PGW5 compoundPGW5 compound binds to CHRM3 protein24389121
D010852PicrotoxinPicrotoxin results in increased expression of CHRM3 mRNA15170462
D010862Pilocarpinebrucine promotes the reaction [Pilocarpine binds to CHRM3 protein]9224827
D010862PilocarpineCHRM3 protein binds to Pilocarpine9224827
D017300PipecuroniumPipecuronium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
D028321Plant Preparations[Estradiol co-treated with Plant Preparations] results in decreased expression of CHRM3 mRNA26945725
C531249Poly(amidoamine)Poly(amidoamine) analog results in decreased expression of CHRM3 mRNA23806026
C027373potassium chromate(VI)potassium chromate(VI) results in increased expression of CHRM3 mRNA22714537
D011192Potassium DichromatePotassium Dichromate results in increased expression of CHRM3 mRNA23608068
D011284PregnenolonePregnenolone inhibits the reaction [Acetylcholine binds to CHRM3 protein]15900516
D011284PregnenolonePregnenolone inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]15900516
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of CHRM3 mRNA19162173
D011374ProgesteroneProgesterone inhibits the reaction [Acetylcholine binds to CHRM3 protein]15900516
D011374ProgesteroneProgesterone inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]15900516
C005556propionaldehydepropionaldehyde results in increased expression of CHRM3 mRNA26079696
D011441PropylthiouracilPropylthiouracil affects the expression of CHRM3 mRNA24780913
D011794QuercetinQuercetin inhibits the reaction [Cadmium Chloride results in decreased expression of CHRM3 mRNA]27389774
D011813Quinuclidinyl BenzilateCrotalid Venoms inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]10845706
D011813Quinuclidinyl BenzilateQuinuclidinyl Benzilate binds to CHRM3 protein10845706
D011813Quinuclidinyl BenzilatePregnenolone inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]15900516
D011813Quinuclidinyl BenzilateProgesterone inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]15900516
D011813Quinuclidinyl Benzilatehexahydrosiladifenidol inhibits the reaction [Quinuclidinyl Benzilate binds to CHRM3 protein]8744975
D011813Quinuclidinyl BenzilateQuinuclidinyl Benzilate binds to CHRM3 protein8744975
C059514resveratrolresveratrol promotes the reaction [CHRM3 protein binds to GJA1 protein]17520802
C061870rocuroniumrocuronium inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
C093642SB 203580SB 203580 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 mRNA]26916448
C093642SB 203580SB 203580 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 protein]26916448
D012602Scopolamine Derivativesmethoctramine inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]12507038
D012602Scopolamine DerivativesScopolamine Derivatives binds to CHRM3 protein12507038
D012602Scopolamine Derivatives"4-diphenylacetoxy-1,1-dimethylpiperidinium inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]"11306684
D012602Scopolamine DerivativesKetamine inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]12456425
D012602Scopolamine DerivativesScopolamine Derivatives binds to CHRM3 protein11306684|1245642
D012602Scopolamine DerivativesThiopental inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]12456425
D012602Scopolamine DerivativesTropicamide inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]11306684
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of CHRM3 mRNA23806026|2589566
D012834SilverSilver results in increased expression of CHRM3 mRNA27131904
C017947sodium arsenitesodium arsenite results in increased expression of CHRM3 mRNA28595984
D000069464Solifenacin SuccinateSolifenacin Succinate binds to and results in decreased activity of CHRM3 protein11488427
D019311StaurosporineStaurosporine binds to CHRM3 protein12435818
D013311Streptozocin1-hexacosanol inhibits the reaction [Streptozocin affects the expression of CHRM3 mRNA]17989502
D013311StreptozocinStreptozocin affects the expression of CHRM3 mRNA17989502
D013331StrychnineStrychnine binds to CHRM3 protein15647330
D013331StrychnineStrychnine binds to CHRM3 protein12435818
D013657Taurodeoxycholic AcidCHRM3 protein results in increased susceptibility to Taurodeoxycholic Acid15964566
D013657Taurodeoxycholic AcidTaurodeoxycholic Acid results in increased activity of CHRM3 protein15964566
D013658Taurolithocholic AcidTaurolithocholic Acid binds to and affects the activity of CHRM3 protein12379313
D013658Taurolithocholic Acid[Taurolithocholic Acid binds to and affects the activity of CHRM3 protein] which results in increased abundance of Inositol Phosphates12379313
D013658Taurolithocholic AcidTaurolithocholic Acid binds to CHRM3 protein12464352
D013739Testosterone[Testosterone co-treated with Calcitriol] results in decreased expression of CHRM3 mRNA21592394
D013739TestosteroneTestosterone results in increased expression of CHRM3 mRNA21592394
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CHRM3 mRNA28922406
D013874ThiopentalThiopental binds to and results in decreased activity of CHRM3 protein12456425
D013874ThiopentalThiopental inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]12456425
D000069447Tiotropium BromideTiotropium Bromide binds to CHRM3 protein21870878
D000068737Tolterodine TartrateTolterodine Tartrate binds to and results in decreased activity of CHRM3 protein15140916
D014212TretinoinTretinoin results in decreased expression of CHRM3 mRNA23724009
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of CHRM3 mRNA24935251|2627250
D014303TrinitrotolueneTrinitrotoluene affects the expression of CHRM3 mRNA21346803
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of CHRM3 mRNA"26179874
D014331TropicamideTropicamide inhibits the reaction [Scopolamine Derivatives binds to CHRM3 protein]11306684
C113580U 0126U 0126 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 mRNA]26916448
C113580U 0126U 0126 inhibits the reaction [Particulate Matter results in increased expression of CHRM3 protein]26916448
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of CHRM3 mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of CHRM3 mRNA24383497|2493525
D014635Valproic AcidValproic Acid results in decreased expression of CHRM3 mRNA24896083
D014673Vecuronium BromideVecuronium Bromide inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]9846649
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CHRM3 mRNA"27188386
C111237vorinostatvorinostat results in increased expression of CHRM3 mRNA26272509|2718838
C086111WIN 51708WIN 51708 binds to CHRM3 protein12435818
C086110WIN 62577WIN 62577 analog binds to CHRM3 protein12435818
C086110WIN 62577WIN 62577 analog inhibits the reaction [Acetylcholine binds to CHRM3 protein]12435818
C086110WIN 62577WIN 62577 promotes the reaction [Acetylcholine binds to CHRM3 protein]12435818
D015034Zinc OxideZinc Oxide promotes the reaction [Carbachol inhibits the reaction [N-Methylscopolamine binds to CHRM3 protein]]20708676
D019287Zinc SulfateZinc Sulfate results in decreased expression of CHRM3 mRNA16330358

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0004435phosphatidylinositol phospholipase C activity-TAS1905013  
GO:0004930G-protein coupled receptor activity-IBA21873635  
GO:0004993G-protein coupled serotonin receptor activity-IBA21873635  
GO:0005515protein binding-IPI19575010  
GO:0016907G-protein coupled acetylcholine receptor activity-IBA21873635  
GO:0016907G-protein coupled acetylcholine receptor activity-ISS-  
GO:0030594neurotransmitter receptor activity-IBA21873635  
GO:0038023signaling receptor activity-TAS10940357  
GO:0042166acetylcholine binding-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0003056regulation of vascular smooth muscle contraction-IBA21873635  
GO:0006464cellular protein modification process-TAS10051746  
GO:0006939smooth muscle contraction-IEA-  
GO:0007165signal transduction-TAS10940357  
GO:0007186G-protein coupled receptor signaling pathway-TAS-  
GO:0007187G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger-IBA21873635  
GO:0007197adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway-IBA21873635  
GO:0007213G-protein coupled acetylcholine receptor signaling pathway-ISS-  
GO:0007268chemical synaptic transmission-IBA21873635  
GO:0007399nervous system development-TAS2739737  
GO:0008283cell proliferation-TAS8063729  
GO:0045987positive regulation of smooth muscle contraction-IEA-  
GO:0046541saliva secretion-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005886plasma membrane-IDA-  
GO:0005886plasma membrane-TAS-  
GO:0005887integral component of plasma membrane-IBA21873635  
GO:0005887integral component of plasma membrane-ISS-  
GO:0016323basolateral plasma membrane-IEA-  
GO:0030054cell junction-IEA-  
GO:0030425dendrite-IBA21873635  
GO:0030425dendrite-IEA-  
GO:0032279asymmetric synapse-IEA-  
GO:0043679axon terminus-IEA-  
GO:0045202synapse-IBA21873635  
GO:0045211postsynaptic membrane-IEA-  
KEGG ID KEGG Term
hsa04020Calcium signaling pathway
hsa04080Neuroactive ligand-receptor interaction
hsa04810Regulation of actin cytoskeleton
hsa04970Salivary secretion
hsa04971Gastric acid secretion
hsa04972Pancreatic secretion
Reactome ID Reactome Term Evidence
R-HSA-1430728MetabolismIEA
R-HSA-162582Signal TransductionTAS
R-HSA-163685Integration of energy metabolismIEA
R-HSA-372790Signaling by GPCRTAS
R-HSA-373076Class A/1 (Rhodopsin-like receptors)TAS
R-HSA-375280Amine ligand-binding receptorsTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-390648Muscarinic acetylcholine receptorsTAS
R-HSA-399997Acetylcholine regulates insulin secretionIEA
R-HSA-416476G alpha (q) signalling eventsTAS
R-HSA-422356Regulation of insulin secretionIEA
R-HSA-500792GPCR ligand bindingTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal